Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
A 2024 systematic review published in the American Journal of Sports Medicine concluded that "clinical data were limited, and in-human safety remains unknown." The FDA has classified BPC-157 as a Category 2 bulk drug substance, meaning it cannot be compounded by commercial pharmacies due to insufficient evidence of human safety
These are typically mild to moderate and often transient, decreasing over time as the body adjusts to the medication
Eur J Mod Med Pract 4:373387 Benites-Zapata VA, Ignacio-Cconchoy FL, Ulloque-Badaracco JR, Hernandez-Bustamante EA, Alarcn-Braga EA, Al-kassab-Crdova A, Herrera-Aazco P (2023) Vitamin B12 levels in thyroid disorders: a systematic review and meta-analysis
As of June 2026, approximately 3,763 gastrointestinal-injury cases were pending in MDL 3094, while a separate MDL for claims involving non-arteritic anterior ischemic optic neuropathy, or NAION, had reached approximately 110 cases
A single-peptide protocol with BPC-157 starts at $445 per cycle, and our most-requested option, the Wolverine Stack that combines BPC-157 with TB-500, is $795 per cycle
US$ 28.00
US$ 23.63
US$ 23.70
